The National Grid has announced that, in a bid to ensure uninterrupted power across Britain this winter, it will offer compensation to households that reduce their electricity consumption.
Poolbeg Pharma PLC (AIM:POLB) AI led programme identifies influenza drug targets
Successful Artificial Intelligence led programme identifies multiple influenza drug targets
Poolbeg Pharma PLC (AIM:POLB) Oral Vaccine Programme Moves Forward
Next-Generation Oral Vaccine Programme Advancing Through Non-Dilutive Funding
Russian army needs a decade to rebuild
More than a year prior, under the guise of common mobs, Russian forces launched a brutal assault on Ukrainian towns and cities, which resulted in a horrifying array of atrocities
UK bypasses Putin as gas prices reach a two-year low
Britain has successfully completed an entire year without importing any Russian gas, striking a significant blow to Vladimir Putin’s energy warfare.
Poolbeg Pharma PLC – Board Appointment
Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a leading biopharmaceutical company focusing on infectious and prevalent diseases with a high unmet medical need, announces the appointment of Brendan Buckley as
Analysts predict a £1,200 decrease in the UK’s household energy price cap coming July.
Analysts anticipate a substantial drop of over £1,200 in the UK’s household energy price cap in July. This is due to a significant decline in wholesale gas and electricity prices,
Household expenses are set to decrease by £500 as Putin’s energy war proves unsuccessful.
Anticipated average household energy bills are set to decrease by approximately £500 starting in July, suggesting that Vladimir Putin’s strategy to leverage Russia’s gas reserves for geopolitical ends has not
Gas prices in Europe revert to standard rates, marking a setback for Putin’s energy conflict.
For the first time since Russia’s Ukraine incursion, European natural gas prices have returned to their typical trading ranges, marking a setback in Vladimir Putin’s energy warfare.
Poolbeg Pharma PLC (AIM:POLB) Annual Report & AGM Notice
Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a leading biopharmaceutical company focusing on infectious and prevalent diseases with a high unmet medical need, confirms that the Company’s
Poolbeg Pharma PLC (AIM:POLB) Results for the year ended 31 December 2022
Significant milestones reached, well capitalised and positioned for future growth